Federal contract award
75F40122C00134
DEVELOPMENT AND VALIDATION OF CRRT-SPECIFIC BETA-LACTAM POPULATION PHARMACOKINETIC MODELS TO GUIDE TREATMENT FOR PATIENTS WITH HOSPITAL-ACQUIRED PNEUMONIA.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $400.0K |
| Current contract value | $400.0K |
| Potential contract value / ceiling | $400.0K |
| Start date | Sep 14, 2022 |
| Current end date | Sep 29, 2025 |
| Potential end date | Sep 29, 2025 |
| Latest award activity | Jun 1, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 1, 2026 | P00003 | $-0 | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT. |
| Jun 27, 2025 | P00002 | $0 | DEVELOPMENT AND VALIDATION OF CRRT-SPECIFIC BETA-LACTAM POPULATION PHARMACOKINETIC MODELS TO GUIDE TREATMENT FOR PATIENTS WITH HOSPITAL-ACQUIRED PNEUMONIA. |
| May 8, 2024 | P00001 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE PERIOD OF PERFORMANCE END DATE FOR THE SUBJECT TASK ORDER. IT IS HEREBY EXTENDED BY 12 MONTHS AS FOLLOWS: FROM: 09/29/2024 TO: 09/29/2025 ALL OTHER TERMS AND CONDITIONS REMAIN THE SAME. |
| Sep 14, 2022 | 0 | $400.0K | DEVELOPMENT AND VALIDATION OF CRRT-SPECIFIC BETA-LACTAM POPULATION PHARMACOKINETIC MODELS TO GUIDE TREATMENT FOR PATIENTS WITH HOSPITAL-ACQUIRED PNEUMONIA. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.